Loading…
Pulmonary Arterial Hypertension in Hospitalized Patients With Polycythemia Vera (from the National Inpatient Database)
•Patients with polycythemia vera have an increased prevalence of PAH.•Polycythemia vera is an independent predictor of PAH.•Patients with P. vera and PAH have an increased risk for in-hospital mortality.The prevalence and pathophysiology of pulmonary arterial hypertension (PAH) in myeloproliferative...
Saved in:
Published in: | The American journal of cardiology 2021-03, Vol.143, p.154-157 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c393t-1c4f3787bd9e5a5e4358717f488a20da23ecbb0d96322e9fbc8fbecf8def558c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c393t-1c4f3787bd9e5a5e4358717f488a20da23ecbb0d96322e9fbc8fbecf8def558c3 |
container_end_page | 157 |
container_issue | |
container_start_page | 154 |
container_title | The American journal of cardiology |
container_volume | 143 |
creator | Stempel, Jessica M. Gopalakrishnan, Akshaya Krishnamoorthy, Parasuram Lo, Kevin Bryan Mittal, Varun Moghbeli, Nazanin Varadi, Gabor Rangaswami, Janani |
description | •Patients with polycythemia vera have an increased prevalence of PAH.•Polycythemia vera is an independent predictor of PAH.•Patients with P. vera and PAH have an increased risk for in-hospital mortality.The prevalence and pathophysiology of pulmonary arterial hypertension (PAH) in myeloproliferative neoplasms are poorly understood and have not been evaluated on larger scale studies. These reports generally focus on all myeloproliferative neoplasms rather than each disease individually. We aim to establish the prevalence and association of PAH in patients with polycythemia vera (P. vera) using the Nationwide Inpatient Sample database. We identified 38,395 patients with a discharge diagnosis of P. vera and 39,395,521 patients without P. vera. Both groups were queried for a concomitant discharge diagnosis of PAH. Unadjusted and multivariate adjusted logistic regression analyses were performed to determine if presence of P. vera predicted PAH after adjusting for clinically relevant risk factors. The prevalence of P. vera was 0.1% of all hospital discharge records. Pulmonary arterial hypertension was more prevalent in patients with P. vera compared with the control population (7.9% vs 1.9%, p |
doi_str_mv | 10.1016/j.amjcard.2020.12.023 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2472104936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914920313503</els_id><sourcerecordid>2472104936</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-1c4f3787bd9e5a5e4358717f488a20da23ecbb0d96322e9fbc8fbecf8def558c3</originalsourceid><addsrcrecordid>eNqFkctu1DAYhS0EokPhEUCW2JRFBt9y8QpV5TKVqjILLkvLsf-ojpI42A7V8DR9lj5ZPZqBRTesbP_6zvmtcxB6TcmaElq979d67I0Ods0IyzO2Jow_QSva1LKgkvKnaEUIYYWkQp6gFzH2-UlpWT1HJ5xzUTdcrtDtdhlGP-mww-chQXB6wJvdDPk-Recn7Ca88XF2SQ_uD1i81cnBlCL-6dIN3vphZ3bpBkan8Q8I-v7urAt-xHmErzOarQd8Oc0HFf6ok251hHcv0bNODxFeHc9T9P3zp28Xm-Lq65fLi_OrwnDJU0GN6Hjd1K2VUOoSBC-bmtadaBrNiNWMg2lbYmXFGQPZtabpWjBdY6Ery8bwU3R28J2D_7VATGp00cAw6An8EhUTNaNESF5l9O0jtPdLyP_fU5JVQtZMZKo8UCb4GAN0ag5uzPkpStS-GdWrYzNq34yiTOVmsu7N0X1pR7D_VH-ryMCHAwA5jt8OgoomZ2bAugAmKevdf1Y8ANcfpF8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2492649724</pqid></control><display><type>article</type><title>Pulmonary Arterial Hypertension in Hospitalized Patients With Polycythemia Vera (from the National Inpatient Database)</title><source>ScienceDirect Freedom Collection</source><creator>Stempel, Jessica M. ; Gopalakrishnan, Akshaya ; Krishnamoorthy, Parasuram ; Lo, Kevin Bryan ; Mittal, Varun ; Moghbeli, Nazanin ; Varadi, Gabor ; Rangaswami, Janani</creator><creatorcontrib>Stempel, Jessica M. ; Gopalakrishnan, Akshaya ; Krishnamoorthy, Parasuram ; Lo, Kevin Bryan ; Mittal, Varun ; Moghbeli, Nazanin ; Varadi, Gabor ; Rangaswami, Janani</creatorcontrib><description>•Patients with polycythemia vera have an increased prevalence of PAH.•Polycythemia vera is an independent predictor of PAH.•Patients with P. vera and PAH have an increased risk for in-hospital mortality.The prevalence and pathophysiology of pulmonary arterial hypertension (PAH) in myeloproliferative neoplasms are poorly understood and have not been evaluated on larger scale studies. These reports generally focus on all myeloproliferative neoplasms rather than each disease individually. We aim to establish the prevalence and association of PAH in patients with polycythemia vera (P. vera) using the Nationwide Inpatient Sample database. We identified 38,395 patients with a discharge diagnosis of P. vera and 39,395,521 patients without P. vera. Both groups were queried for a concomitant discharge diagnosis of PAH. Unadjusted and multivariate adjusted logistic regression analyses were performed to determine if presence of P. vera predicted PAH after adjusting for clinically relevant risk factors. The prevalence of P. vera was 0.1% of all hospital discharge records. Pulmonary arterial hypertension was more prevalent in patients with P. vera compared with the control population (7.9% vs 1.9%, p <0.0001). Presence of P. vera was a determinant of PAH in unadjusted analysis (odds ratio 4.4 [4.1 to 4.8]; p <0.001). After adjusting for age, gender, race, diabetes, tobacco use, previous history of tumor, previous history of pulmonary embolism, chronic lung disease, and chronic kidney disease, P. vera was associated with nearly a 3-fold higher risk for PAH after adjusting for several risk factors (2.98 [2.7 to 3.2], p <0.001).</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2020.12.023</identifier><identifier>PMID: 33347839</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age Distribution ; Aged ; Blood cancer ; Cardiovascular diseases ; Chronic illnesses ; Congestive heart failure ; Coronary artery disease ; Cytokines ; Diabetes ; Endothelium ; Female ; Heart diseases ; Hemodynamics ; Hospital Mortality ; Hospitalization ; Humans ; Hypertension ; Kidney diseases ; Kinases ; Logistic Models ; Lung diseases ; Male ; Microenvironments ; Middle Aged ; Mortality ; Multivariate Analysis ; Odds Ratio ; Patients ; Polycythemia ; Polycythemia vera ; Polycythemia Vera - epidemiology ; Population ; Prevalence ; Pulmonary Arterial Hypertension - epidemiology ; Pulmonary embolisms ; Pulmonary hypertension ; Quality of life ; Risk analysis ; Risk Factors ; Sex Distribution ; Sickle cell disease ; Thromboembolism ; Tobacco ; United States - epidemiology</subject><ispartof>The American journal of cardiology, 2021-03, Vol.143, p.154-157</ispartof><rights>2020 Elsevier Inc.</rights><rights>2020. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-1c4f3787bd9e5a5e4358717f488a20da23ecbb0d96322e9fbc8fbecf8def558c3</citedby><cites>FETCH-LOGICAL-c393t-1c4f3787bd9e5a5e4358717f488a20da23ecbb0d96322e9fbc8fbecf8def558c3</cites><orcidid>0000-0001-9162-0579 ; 0000-0001-7088-6677 ; 0000-0001-6099-2142 ; 0000-0001-7117-6677</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33347839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stempel, Jessica M.</creatorcontrib><creatorcontrib>Gopalakrishnan, Akshaya</creatorcontrib><creatorcontrib>Krishnamoorthy, Parasuram</creatorcontrib><creatorcontrib>Lo, Kevin Bryan</creatorcontrib><creatorcontrib>Mittal, Varun</creatorcontrib><creatorcontrib>Moghbeli, Nazanin</creatorcontrib><creatorcontrib>Varadi, Gabor</creatorcontrib><creatorcontrib>Rangaswami, Janani</creatorcontrib><title>Pulmonary Arterial Hypertension in Hospitalized Patients With Polycythemia Vera (from the National Inpatient Database)</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>•Patients with polycythemia vera have an increased prevalence of PAH.•Polycythemia vera is an independent predictor of PAH.•Patients with P. vera and PAH have an increased risk for in-hospital mortality.The prevalence and pathophysiology of pulmonary arterial hypertension (PAH) in myeloproliferative neoplasms are poorly understood and have not been evaluated on larger scale studies. These reports generally focus on all myeloproliferative neoplasms rather than each disease individually. We aim to establish the prevalence and association of PAH in patients with polycythemia vera (P. vera) using the Nationwide Inpatient Sample database. We identified 38,395 patients with a discharge diagnosis of P. vera and 39,395,521 patients without P. vera. Both groups were queried for a concomitant discharge diagnosis of PAH. Unadjusted and multivariate adjusted logistic regression analyses were performed to determine if presence of P. vera predicted PAH after adjusting for clinically relevant risk factors. The prevalence of P. vera was 0.1% of all hospital discharge records. Pulmonary arterial hypertension was more prevalent in patients with P. vera compared with the control population (7.9% vs 1.9%, p <0.0001). Presence of P. vera was a determinant of PAH in unadjusted analysis (odds ratio 4.4 [4.1 to 4.8]; p <0.001). After adjusting for age, gender, race, diabetes, tobacco use, previous history of tumor, previous history of pulmonary embolism, chronic lung disease, and chronic kidney disease, P. vera was associated with nearly a 3-fold higher risk for PAH after adjusting for several risk factors (2.98 [2.7 to 3.2], p <0.001).</description><subject>Age Distribution</subject><subject>Aged</subject><subject>Blood cancer</subject><subject>Cardiovascular diseases</subject><subject>Chronic illnesses</subject><subject>Congestive heart failure</subject><subject>Coronary artery disease</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Endothelium</subject><subject>Female</subject><subject>Heart diseases</subject><subject>Hemodynamics</subject><subject>Hospital Mortality</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Kidney diseases</subject><subject>Kinases</subject><subject>Logistic Models</subject><subject>Lung diseases</subject><subject>Male</subject><subject>Microenvironments</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Multivariate Analysis</subject><subject>Odds Ratio</subject><subject>Patients</subject><subject>Polycythemia</subject><subject>Polycythemia vera</subject><subject>Polycythemia Vera - epidemiology</subject><subject>Population</subject><subject>Prevalence</subject><subject>Pulmonary Arterial Hypertension - epidemiology</subject><subject>Pulmonary embolisms</subject><subject>Pulmonary hypertension</subject><subject>Quality of life</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Sex Distribution</subject><subject>Sickle cell disease</subject><subject>Thromboembolism</subject><subject>Tobacco</subject><subject>United States - epidemiology</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkctu1DAYhS0EokPhEUCW2JRFBt9y8QpV5TKVqjILLkvLsf-ojpI42A7V8DR9lj5ZPZqBRTesbP_6zvmtcxB6TcmaElq979d67I0Ods0IyzO2Jow_QSva1LKgkvKnaEUIYYWkQp6gFzH2-UlpWT1HJ5xzUTdcrtDtdhlGP-mww-chQXB6wJvdDPk-Recn7Ca88XF2SQ_uD1i81cnBlCL-6dIN3vphZ3bpBkan8Q8I-v7urAt-xHmErzOarQd8Oc0HFf6ok251hHcv0bNODxFeHc9T9P3zp28Xm-Lq65fLi_OrwnDJU0GN6Hjd1K2VUOoSBC-bmtadaBrNiNWMg2lbYmXFGQPZtabpWjBdY6Ery8bwU3R28J2D_7VATGp00cAw6An8EhUTNaNESF5l9O0jtPdLyP_fU5JVQtZMZKo8UCb4GAN0ag5uzPkpStS-GdWrYzNq34yiTOVmsu7N0X1pR7D_VH-ryMCHAwA5jt8OgoomZ2bAugAmKevdf1Y8ANcfpF8</recordid><startdate>20210315</startdate><enddate>20210315</enddate><creator>Stempel, Jessica M.</creator><creator>Gopalakrishnan, Akshaya</creator><creator>Krishnamoorthy, Parasuram</creator><creator>Lo, Kevin Bryan</creator><creator>Mittal, Varun</creator><creator>Moghbeli, Nazanin</creator><creator>Varadi, Gabor</creator><creator>Rangaswami, Janani</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9162-0579</orcidid><orcidid>https://orcid.org/0000-0001-7088-6677</orcidid><orcidid>https://orcid.org/0000-0001-6099-2142</orcidid><orcidid>https://orcid.org/0000-0001-7117-6677</orcidid></search><sort><creationdate>20210315</creationdate><title>Pulmonary Arterial Hypertension in Hospitalized Patients With Polycythemia Vera (from the National Inpatient Database)</title><author>Stempel, Jessica M. ; Gopalakrishnan, Akshaya ; Krishnamoorthy, Parasuram ; Lo, Kevin Bryan ; Mittal, Varun ; Moghbeli, Nazanin ; Varadi, Gabor ; Rangaswami, Janani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-1c4f3787bd9e5a5e4358717f488a20da23ecbb0d96322e9fbc8fbecf8def558c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age Distribution</topic><topic>Aged</topic><topic>Blood cancer</topic><topic>Cardiovascular diseases</topic><topic>Chronic illnesses</topic><topic>Congestive heart failure</topic><topic>Coronary artery disease</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Endothelium</topic><topic>Female</topic><topic>Heart diseases</topic><topic>Hemodynamics</topic><topic>Hospital Mortality</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Kidney diseases</topic><topic>Kinases</topic><topic>Logistic Models</topic><topic>Lung diseases</topic><topic>Male</topic><topic>Microenvironments</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Multivariate Analysis</topic><topic>Odds Ratio</topic><topic>Patients</topic><topic>Polycythemia</topic><topic>Polycythemia vera</topic><topic>Polycythemia Vera - epidemiology</topic><topic>Population</topic><topic>Prevalence</topic><topic>Pulmonary Arterial Hypertension - epidemiology</topic><topic>Pulmonary embolisms</topic><topic>Pulmonary hypertension</topic><topic>Quality of life</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Sex Distribution</topic><topic>Sickle cell disease</topic><topic>Thromboembolism</topic><topic>Tobacco</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stempel, Jessica M.</creatorcontrib><creatorcontrib>Gopalakrishnan, Akshaya</creatorcontrib><creatorcontrib>Krishnamoorthy, Parasuram</creatorcontrib><creatorcontrib>Lo, Kevin Bryan</creatorcontrib><creatorcontrib>Mittal, Varun</creatorcontrib><creatorcontrib>Moghbeli, Nazanin</creatorcontrib><creatorcontrib>Varadi, Gabor</creatorcontrib><creatorcontrib>Rangaswami, Janani</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Physical Education Index</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stempel, Jessica M.</au><au>Gopalakrishnan, Akshaya</au><au>Krishnamoorthy, Parasuram</au><au>Lo, Kevin Bryan</au><au>Mittal, Varun</au><au>Moghbeli, Nazanin</au><au>Varadi, Gabor</au><au>Rangaswami, Janani</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulmonary Arterial Hypertension in Hospitalized Patients With Polycythemia Vera (from the National Inpatient Database)</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2021-03-15</date><risdate>2021</risdate><volume>143</volume><spage>154</spage><epage>157</epage><pages>154-157</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>•Patients with polycythemia vera have an increased prevalence of PAH.•Polycythemia vera is an independent predictor of PAH.•Patients with P. vera and PAH have an increased risk for in-hospital mortality.The prevalence and pathophysiology of pulmonary arterial hypertension (PAH) in myeloproliferative neoplasms are poorly understood and have not been evaluated on larger scale studies. These reports generally focus on all myeloproliferative neoplasms rather than each disease individually. We aim to establish the prevalence and association of PAH in patients with polycythemia vera (P. vera) using the Nationwide Inpatient Sample database. We identified 38,395 patients with a discharge diagnosis of P. vera and 39,395,521 patients without P. vera. Both groups were queried for a concomitant discharge diagnosis of PAH. Unadjusted and multivariate adjusted logistic regression analyses were performed to determine if presence of P. vera predicted PAH after adjusting for clinically relevant risk factors. The prevalence of P. vera was 0.1% of all hospital discharge records. Pulmonary arterial hypertension was more prevalent in patients with P. vera compared with the control population (7.9% vs 1.9%, p <0.0001). Presence of P. vera was a determinant of PAH in unadjusted analysis (odds ratio 4.4 [4.1 to 4.8]; p <0.001). After adjusting for age, gender, race, diabetes, tobacco use, previous history of tumor, previous history of pulmonary embolism, chronic lung disease, and chronic kidney disease, P. vera was associated with nearly a 3-fold higher risk for PAH after adjusting for several risk factors (2.98 [2.7 to 3.2], p <0.001).</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33347839</pmid><doi>10.1016/j.amjcard.2020.12.023</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-9162-0579</orcidid><orcidid>https://orcid.org/0000-0001-7088-6677</orcidid><orcidid>https://orcid.org/0000-0001-6099-2142</orcidid><orcidid>https://orcid.org/0000-0001-7117-6677</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 2021-03, Vol.143, p.154-157 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_proquest_miscellaneous_2472104936 |
source | ScienceDirect Freedom Collection |
subjects | Age Distribution Aged Blood cancer Cardiovascular diseases Chronic illnesses Congestive heart failure Coronary artery disease Cytokines Diabetes Endothelium Female Heart diseases Hemodynamics Hospital Mortality Hospitalization Humans Hypertension Kidney diseases Kinases Logistic Models Lung diseases Male Microenvironments Middle Aged Mortality Multivariate Analysis Odds Ratio Patients Polycythemia Polycythemia vera Polycythemia Vera - epidemiology Population Prevalence Pulmonary Arterial Hypertension - epidemiology Pulmonary embolisms Pulmonary hypertension Quality of life Risk analysis Risk Factors Sex Distribution Sickle cell disease Thromboembolism Tobacco United States - epidemiology |
title | Pulmonary Arterial Hypertension in Hospitalized Patients With Polycythemia Vera (from the National Inpatient Database) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A08%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulmonary%20Arterial%20Hypertension%20in%20Hospitalized%20Patients%20With%20Polycythemia%20Vera%C2%A0(from%20the%20National%20Inpatient%20Database)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Stempel,%20Jessica%20M.&rft.date=2021-03-15&rft.volume=143&rft.spage=154&rft.epage=157&rft.pages=154-157&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2020.12.023&rft_dat=%3Cproquest_cross%3E2472104936%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-1c4f3787bd9e5a5e4358717f488a20da23ecbb0d96322e9fbc8fbecf8def558c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2492649724&rft_id=info:pmid/33347839&rfr_iscdi=true |